METRO PLUS

Battling swine flu

HEALTH An intra-nasal vaccine to tackle swine flu is launched

N ow, a Pune-based indigenous vaccine manufacturer Serum Institute of India (SII), one of the largest vaccine manufacturers of the world, has come up with a painless nasal vaccine called Nasovac. At a recently organised press conference to announce the launch , it was revealed that the single dose vaccine, fitted at the top of a syringe, is just to be sniffed once in each nostril making it a painless prevention mode. Speaking on the occasion, SII's Chairman, Dr. Cyrus Poonawalla said, “Nasovac is approved by the Drug Controller General of India (DCGI) for usage by any individual above three years of age, except pregnant women.” He added, “It is the most economically priced swine flu vaccine in the market. At present you have to pay Rs.158 per dose.” Currently, there are around 1.5 crore doses available in the market.

The vaccine is available in a pack of five doses. With no side-effects, Poonawalla claims it to be an effective tool in fighting the pandemic that took over 1,000 lives in the country since its outbreak in May last year.

Dr. Prasad Kulkarni giving a demonstration of how to administer the vaccine, pointed out, “Along with a needle prick free benefit, Nasovac has a superior profile based on its administration through the respiratory route – it mimics the path followed by the virus to enter the body. The safety and efficiency was tested through clinical trails conducted in India for the vaccine.”



Recommended for you